 "Lupin Pharma")
Shares of Lupin dipped 3% to Rs 1,242, its fresh 32-month low on BSE in intra-day trade, on reported that US health regulator issued eight observations for its Aurangabad plant. The stock is currently trading at its lowest level since August 26, 2014.
The exchange has sought clarification from Lupin with respect to news article appearing on CNBC TV18 on May 9, 2017 titled "USFDA issues 8 observations for Lupin Aurangabad Plant."
The reply is awaited.
“The US Food and Drug Administration (FDA) issued eight observations for its Aurangabad unit, which was inspected between April 17 and
The exchange has sought clarification from Lupin with respect to news article appearing on CNBC TV18 on May 9, 2017 titled "USFDA issues 8 observations for Lupin Aurangabad Plant."
The reply is awaited.
“The US Food and Drug Administration (FDA) issued eight observations for its Aurangabad unit, which was inspected between April 17 and
